| Year |
Citation |
Score |
| 2024 |
Reshetnyak YK, Andreev OA, Engelman DM. Aiming the magic bullet: targeted delivery of imaging and therapeutic agents to solid tumors by pHLIP peptides. Frontiers in Pharmacology. 15: 1355893. PMID 38545547 DOI: 10.3389/fphar.2024.1355893 |
0.355 |
|
| 2024 |
Moshnikova A, DuPont M, Iraca M, Klumpp C, Visca H, Allababidi D, Pelzer P, Engelman DM, Andreev OA, Reshetnyak YK. Targeted intracellular delivery of dimeric STINGa by two pHLIP peptides for treatment of solid tumors. Frontiers in Pharmacology. 15: 1346756. PMID 38495104 DOI: 10.3389/fphar.2024.1346756 |
0.375 |
|
| 2024 |
DuPont M, Klumpp C, Iraca M, Allababidi D, Visca H, Engelman DM, Andreev OA, Moshnikova A, Reshetnyak YK. pHLIP targeted intracellular delivery of calicheamicin. International Journal of Pharmaceutics. 654: 123954. PMID 38428548 DOI: 10.1016/j.ijpharm.2024.123954 |
0.345 |
|
| 2023 |
Matsui T, Toda Y, Sato H, Itagaki R, Konishi K, Moshnikova A, Andreev OA, Hosogi S, Reshetnyak YK, Ashihara E. Targeting acidic pre-metastatic niche in lungs by pH low insertion peptide and its utility for anti-metastatic therapy. Frontiers in Oncology. 13: 1258442. PMID 38033489 DOI: 10.3389/fonc.2023.1258442 |
0.312 |
|
| 2023 |
Silva TFD, Visca H, Klumpp C, Andreev OA, Reshetnyak YK, Machuqueiro M. Arginine Residues Modulate the Membrane Interactions of pHLIP Peptides. Journal of Chemical Information and Modeling. 63: 4433-4446. PMID 37395685 DOI: 10.1021/acs.jcim.3c00360 |
0.321 |
|
| 2023 |
DuPont M, Visca H, Moshnikova A, Engelman DM, Reshetnyak YK, Andreev OA. Tumor treatment by pHLIP-targeted antigen delivery. Frontiers in Bioengineering and Biotechnology. 10: 1082290. PMID 36686229 DOI: 10.3389/fbioe.2022.1082290 |
0.337 |
|
| 2022 |
Moshnikova A, Golijanin B, Amin A, Doyle J, Kott O, Gershman B, DuPont M, Li Y, Lu X, Engelman DM, Andreev OA, Reshetnyak YK, Golijanin D. Targeting Bladder Urothelial Carcinoma with pHLIP-ICG and Inhibition of Urothelial Cancer Cell Proliferation by pHLIP-amanitin. Frontiers in Urology. 2. PMID 36439552 DOI: 10.3389/fruro.2022.868919 |
0.307 |
|
| 2022 |
Moshnikova A, DuPont M, Visca H, Engelman DM, Andreev OA, Reshetnyak YK. Eradication of tumors and development of anti-cancer immunity using STINGa targeted by pHLIP. Frontiers in Oncology. 12: 1023959. PMID 36330464 DOI: 10.3389/fonc.2022.1023959 |
0.302 |
|
| 2022 |
Bauer D, Visca H, Weerakkody A, Carter LM, Samuels Z, Kaminsky S, Andreev OA, Reshetnyak YK, Lewis JS. PET Imaging of Acidic Tumor Environment With Zr-labeled pHLIP Probes. Frontiers in Oncology. 12: 882541. PMID 35664740 DOI: 10.3389/fonc.2022.882541 |
0.358 |
|
| 2022 |
Visca H, DuPont M, Moshnikova A, Crawford T, Engelman DM, Andreev OA, Reshetnyak YK. pHLIP Peptides Target Acidity in Activated Macrophages. Molecular Imaging and Biology. PMID 35604527 DOI: 10.1007/s11307-022-01737-x |
0.325 |
|
| 2021 |
Gayle S, Aiello R, Leelatian N, Beckta JM, Bechtold J, Bourassa P, Csengery J, Maguire RJ, Marshall D, Sundaram RK, Van Doorn J, Jones K, Moore H, Lopresti-Morrow L, Paradis T, ... ... Andreev OA, et al. Correction to 'Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity'. Nar Cancer. 3: zcab047. PMID 34888524 DOI: 10.1093/narcan/zcab047 |
0.322 |
|
| 2021 |
Gayle S, Aiello R, Leelatian N, Beckta JM, Bechtold J, Bourassa P, Csengery J, Maguire RJ, Marshall D, Sundaram RK, Van Doorn J, Jones K, Moore H, Lopresti-Morrow L, Paradis T, ... ... Andreev OA, et al. Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity. Nar Cancer. 3: zcab021. PMID 34316708 DOI: 10.1093/narcan/zcab021 |
0.322 |
|
| 2020 |
Wu H, Estrella V, Beatty M, Abrahams D, El-Kenawi A, Russell S, Ibrahim-Hashim A, Longo DL, Reshetnyak YK, Moshnikova A, Andreev OA, Luddy K, Damaghi M, Kodumudi K, Pillai SR, et al. T-cells produce acidic niches in lymph nodes to suppress their own effector functions. Nature Communications. 11: 4113. PMID 32807791 DOI: 10.1038/S41467-020-17756-7 |
0.325 |
|
| 2020 |
Reshetnyak YK, Moshnikova A, Andreev OA, Engelman DM. Targeting Acidic Diseased Tissues by pH-Triggered Membrane-Associated Peptide Folding. Frontiers in Bioengineering and Biotechnology. 8: 335. PMID 32411684 DOI: 10.3389/Fbioe.2020.00335 |
0.427 |
|
| 2020 |
Slaybaugh G, Weerakkody D, Engelman DM, Andreev OA, Reshetnyak YK. Kinetics of pHLIP peptide insertion into and exit from a membrane. Proceedings of the National Academy of Sciences of the United States of America. PMID 32409607 DOI: 10.1073/Pnas.1917857117 |
0.466 |
|
| 2020 |
Henry KE, Chaney AM, Nagle VL, Cropper HC, Mozaffari S, Slaybaugh G, Parang K, Andreev O, Reshetnyak YK, James ML, Lewis JS. Demarcation of Sepsis-Induced Peripheral and Central Acidosis with pH-Low Insertion Cyclic (pHLIC) Peptide. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32005774 DOI: 10.2967/Jnumed.119.233072 |
0.312 |
|
| 2019 |
Wei D, Engelman DM, Reshetnyak YK, Andreev OA. Mapping pH at Cancer Cell Surfaces. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 30989440 DOI: 10.1007/S11307-019-01335-4 |
0.337 |
|
| 2019 |
Brito J, Golijanin B, Kott O, Moshnikova A, Mueller-Leonhard C, Gershman B, Andreev OA, Reshetnyak YK, Amin A, Golijanin D. Ex-vivo Imaging of Upper Tract Urothelial Carcinoma Using Novel ICG-Var3 pHLIP Imaging Agent. Urology. PMID 30659902 DOI: 10.1016/J.Urology.2019.01.008 |
0.347 |
|
| 2019 |
Golijanin B, Moshnikova A, Engelman DM, Andreev OA, Reshetnyak YK, Amin A, Golijanin D. Abstract 1399: Ex-vivo targeting of urothelial carcinomas by fluorescent pHLIP imaging agents Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-1399 |
0.314 |
|
| 2019 |
Paralkar V, Aiello RJ, Marshall D, Csengery J, Bourassa P, Zhang Q, Robinson BS, Lopresti-Morrow L, Bechtold J, Tylaska L, Paradis T, Slaybaugh G, Visca H, Moshnikova A, Weerakkody D, ... Andreev O, et al. Abstract 2981: Targeting solid tumor acidic microenvironment with an alphalex PARP inhibitor Cancer Research. 79: 2981-2981. DOI: 10.1158/1538-7445.Am2019-2981 |
0.445 |
|
| 2019 |
Crawford T, Moshnikova A, Roles S, Carter LM, Lewis JS, Engelman DM, Andreev OA, Reshetnyak YK. Abstract 1956: ICG pHLIP: A novel agent for fluorescence-guided surgery Cancer Research. 79: 1956-1956. DOI: 10.1158/1538-7445.Am2019-1956 |
0.45 |
|
| 2019 |
Reshetnyak YK, Andreev OA, Engelman D. Abstract A102: pHLIP technology for targeting acidity at surface of tumor cells and extracellular and intracellular delivery of imaging and therapeutic agents Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-A102 |
0.506 |
|
| 2018 |
Rinaldi F, Hanieh PN, Del Favero E, Rondelli V, Brocca P, Pereira MC, Andreev OA, Reshetnyak YK, Marianecci C, Carafa M. Decoration of Nanovesicles with pH (Low) Insertion Peptide (pHLIP) for Targeted Delivery. Nanoscale Research Letters. 13: 391. PMID 30515583 DOI: 10.1186/S11671-018-2807-8 |
0.526 |
|
| 2018 |
Karabadzhak AG, Weerakkody D, Deacon J, Andreev OA, Reshetnyak YK, Engelman DM. Bilayer Thickness and Curvature Influence Binding and Insertion of a pHLIP Peptide. Biophysical Journal. 114: 2107-2115. PMID 29742404 DOI: 10.1016/J.Bpj.2018.03.036 |
0.447 |
|
| 2018 |
Vila-Viçosa D, Silva TFD, Slaybaugh G, Reshetnyak YK, Andreev OA, Machuqueiro M. The membrane-induced p K shifts in wt-pHLIP and its L16H variant. Journal of Chemical Theory and Computation. PMID 29733633 DOI: 10.1021/Acs.Jctc.8B00102 |
0.431 |
|
| 2018 |
Wyatt LC, Moshnikova A, Crawford T, Engelman DM, Andreev OA, Reshetnyak YK. Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors. Proceedings of the National Academy of Sciences of the United States of America. PMID 29507241 DOI: 10.1073/Pnas.1715350115 |
0.548 |
|
| 2017 |
Daniels JL, Crawford TM, Andreev OA, Reshetnyak YK. Synthesis and characterization of pHLIP(®) coated gold nanoparticles. Biochemistry and Biophysics Reports. 10: 62-69. PMID 28955736 DOI: 10.1016/J.Bbrep.2017.02.008 |
0.34 |
|
| 2017 |
Pereira MC, Pianella M, Wei D, Moshnikova A, Marianecci C, Carafa M, Andreev OA, Reshetnyak YK. pH-sensitive pHLIP(®) coated niosomes. Molecular Membrane Biology. 1-13. PMID 28792261 DOI: 10.1080/09687688.2017.1342969 |
0.453 |
|
| 2017 |
Wyatt LC, Lewis JS, Andreev OA, Reshetnyak YK, Engelman DM. Applications of pHLIP Technology for Cancer Imaging and Therapy. Trends in Biotechnology. PMID 28438340 DOI: 10.1016/J.Tibtech.2017.03.014 |
0.458 |
|
| 2017 |
Wyatt LC, Moshnikova A, Crawford T, Andreev OA, Reshetnyak YK. Abstract 5137: Utility of pH (low) insertion peptide (pHLIP® peptide) variants in drug delivery Cancer Research. 77: 5137-5137. DOI: 10.1158/1538-7445.Am2017-5137 |
0.564 |
|
| 2016 |
Weerakkody D, Andreev OA, Reshetnyak YK. Insertion into lipid bilayer of truncated pHLIP(®)peptide. Biochemistry and Biophysics Reports. 8: 290-295. PMID 28664189 DOI: 10.1016/J.Bbrep.2016.10.001 |
0.493 |
|
| 2016 |
Narayanan T, Weerakkody D, Karabadzhak AG, Anderson M, Andreev OA, Reshetnyak YK. pHLIP® Peptide Interaction With Membrane Monitored by SAXS. The Journal of Physical Chemistry. B. PMID 27726396 DOI: 10.1021/Acs.Jpcb.6B06643 |
0.484 |
|
| 2016 |
Golijanin J, Amin A, Moshnikova A, Brito JM, Tran TY, Adochite RC, Andreev GO, Crawford T, Engelman DM, Andreev OA, Reshetnyak YK, Golijanin D. Targeted imaging of urothelium carcinoma in human bladders by an ICG pHLIP peptide ex vivo. Proceedings of the National Academy of Sciences of the United States of America. PMID 27688767 DOI: 10.1073/Pnas.1610472113 |
0.41 |
|
| 2016 |
Weerakkody D, Moshnikova A, El-Sayed NS, Adochite RC, Slaybaugh G, Golijanin J, Tiwari RK, Andreev OA, Parang K, Reshetnyak YK. Novel pH-Sensitive Cyclic Peptides. Scientific Reports. 6: 31322. PMID 27515582 DOI: 10.1038/Srep31322 |
0.519 |
|
| 2016 |
Demoin DW, Wyatt LC, Edwards KJ, Abdel-Atti D, Sarparanta MP, Pourat J, Longo VA, Carlin SD, Engelman DM, Andreev OA, Reshetnyak YK, Viola-Villegas N, Lewis JS. PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-labeled pHLIP peptides: A Structure-Activity Optimization Study. Bioconjugate Chemistry. PMID 27396694 DOI: 10.1021/Acs.Bioconjchem.6B00306 |
0.448 |
|
| 2016 |
Anderson M, Moshnikova A, Engelman DM, Reshetnyak YK, Andreev OA. Probe for the measurement of cell surface pH in vivo and ex vivo. Proceedings of the National Academy of Sciences of the United States of America. PMID 27382181 DOI: 10.1073/Pnas.1608247113 |
0.462 |
|
| 2016 |
Adochite RC, Moshnikova A, Golijanin J, Andreev OA, Katenka NV, Reshetnyak YK. Comparative Study of Tumor Targeting and Biodistribution of pH (Low) Insertion Peptides (pHLIP(®) Peptides) Conjugated with Different Fluorescent Dyes. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 27074841 DOI: 10.1007/S11307-016-0949-6 |
0.538 |
|
| 2016 |
Moshnikova A, Anderson M, Adochite R, Engelman DM, Andreev OA, Reshetnyak YK. Abstract 4250: pHLIP® technology for imaging acidic tumors Cancer Research. 76: 4250-4250. DOI: 10.1158/1538-7445.Am2016-4250 |
0.52 |
|
| 2016 |
Demoin DW, Edwards KJ, Wyatt LC, Sarparanta M, Pourat J, Andreev OA, Reshetnyak YK, Viola-Villegas N, Lewis JS. Abstract 4205: Targeting a variety of cancers with NOTA-derivatized pH (low) insertion peptide (pHLIP) complexes with64Cu and18F: What cancers are targetable Cancer Research. 76: 4205-4205. DOI: 10.1158/1538-7445.Am2016-4205 |
0.486 |
|
| 2016 |
Engelman D, Reshetnyak YK, Andreev OA. pHLIP®: Uses in Measuring Cell Surface pH, Imaging Tumors, and Delivering Therapeutics Biophysical Journal. 110: 418a. DOI: 10.1016/J.Bpj.2015.11.2259 |
0.541 |
|
| 2015 |
Sharma GP, Reshetnyak YK, Andreev OA, Karbach M, Müller G. Coil-helix transition of polypeptide at water-lipid interface. Journal of Statistical Mechanics (Online). 2015. PMID 31456824 DOI: 10.1088/1742-5468/2015/01/P01034 |
0.301 |
|
| 2015 |
Tapmeier TT, Moshnikova A, Beech J, Allen D, Kinchesh P, Smart S, Harris A, McIntyre A, Engelman DM, Andreev OA, Reshetnyak YK, Muschel RJ. The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions. Proceedings of the National Academy of Sciences of the United States of America. 112: 9710-5. PMID 26195776 DOI: 10.1073/Pnas.1509488112 |
0.462 |
|
| 2015 |
Arachchige MC, Reshetnyak YK, Andreev OA. Advanced targeted nanomedicine. Journal of Biotechnology. 202: 88-97. PMID 25615945 DOI: 10.1016/J.Jbiotec.2015.01.009 |
0.347 |
|
| 2015 |
Cruz-Monserrate Z, Roland CL, Deng D, Arumugam T, Moshnikova A, Andreev OA, Reshetnyak Y, Logsdon CD. Abstract B24: Targeting pancreatic ductal adenocarcinoma acidic microenvironment Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-B24 |
0.391 |
|
| 2015 |
Adochite RC, Moshnikova A, Andreev OA, Reshetnyak YK. PH (Low) Insertion Peptide targets 4T1 mammary tumors 2015 41st Annual Northeast Biomedical Engineering Conference, Nebec 2015. DOI: 10.1109/NEBEC.2015.7117142 |
0.408 |
|
| 2015 |
Karabadzhak AG, Weerakkody D, Andreev OA, Reshetnyak YK, Engelman DM. Lipid Composition Influences the Insertion and Folding of pHLIP Peptides Biophysical Journal. 108: 555a. DOI: 10.1016/J.Bpj.2014.11.3042 |
0.452 |
|
| 2014 |
Karabadzhak AG, An M, Yao L, Langenbacher R, Moshnikova A, Adochite RC, Andreev OA, Reshetnyak YK, Engelman DM. pHLIP-FIRE, a cell insertion-triggered fluorescent probe for imaging tumors demonstrates targeted cargo delivery in vivo. Acs Chemical Biology. 9: 2545-53. PMID 25184440 DOI: 10.1021/Cb500388M |
0.476 |
|
| 2014 |
Adochite RC, Moshnikova A, Carlin SD, Guerrieri RA, Andreev OA, Lewis JS, Reshetnyak YK. Targeting breast tumors with pH (low) insertion peptides. Molecular Pharmaceutics. 11: 2896-905. PMID 25004202 DOI: 10.1021/Mp5002526 |
0.466 |
|
| 2014 |
Viola-Villegas NT, Carlin SD, Ackerstaff E, Sevak KK, Divilov V, Serganova I, Kruchevsky N, Anderson M, Blasberg RG, Andreev OA, Engelman DM, Koutcher JA, Reshetnyak YK, Lewis JS. Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 111: 7254-9. PMID 24785505 DOI: 10.1073/Pnas.1405240111 |
0.437 |
|
| 2014 |
Andreev OA, Engelman DM, Reshetnyak YK. Targeting diseased tissues by pHLIP insertion at low cell surface pH. Frontiers in Physiology. 5: 97. PMID 24659971 DOI: 10.3389/Fphys.2014.00097 |
0.496 |
|
| 2014 |
Cruz-Monserrate Z, Roland CL, Deng D, Arumugam T, Moshnikova A, Andreev OA, Reshetnyak YK, Logsdon CD. Targeting pancreatic ductal adenocarcinoma acidic microenvironment. Scientific Reports. 4: 4410. PMID 24642931 DOI: 10.1038/Srep04410 |
0.406 |
|
| 2014 |
Karabadzhak A, Yao L, Langenbacher R, Moshnikova A, Adochite R, An M, Andreev OA, Reshetnyak YK, Engelman DM. Phlip-Fire: A High-Contrast, Insertion-Triggered Fluorescent Probe for Targeting Tumors In Vivo Biophysical Journal. 106: 88a-89a. DOI: 10.1016/J.Bpj.2013.11.561 |
0.522 |
|
| 2014 |
Engelman DM, An M, Andreev OA, Barrera FN, Bahal R, Bosenberg MW, Cheng C, Glazer PM, Karabadzhak A, Reshetnyak YK, Saltzman WM, Slack FJ, Svoronos AA, Thevenin D. Imaging and Treating Tumors by Targeting their Acidity with Phlip, a Ph-Sensitve Insertion Peptide Biophysical Journal. 106: 231a. DOI: 10.1016/J.Bpj.2013.11.1350 |
0.542 |
|
| 2013 |
Wijesinghe D, Arachchige MC, Lu A, Reshetnyak YK, Andreev OA. pH dependent transfer of nano-pores into membrane of cancer cells to induce apoptosis. Scientific Reports. 3: 3560. PMID 24356337 DOI: 10.1038/Srep03560 |
0.437 |
|
| 2013 |
Weerakkody D, Moshnikova A, Thakur MS, Moshnikova V, Daniels J, Engelman DM, Andreev OA, Reshetnyak YK. Family of pH (low) insertion peptides for tumor targeting. Proceedings of the National Academy of Sciences of the United States of America. 110: 5834-9. PMID 23530249 DOI: 10.1073/Pnas.1303708110 |
0.515 |
|
| 2013 |
Yao L, Daniels J, Wijesinghe D, Andreev OA, Reshetnyak YK. pHLIP®-mediated delivery of PEGylated liposomes to cancer cells. Journal of Controlled Release : Official Journal of the Controlled Release Society. 167: 228-37. PMID 23416366 DOI: 10.1016/J.Jconrel.2013.01.037 |
0.485 |
|
| 2013 |
Moshnikova A, Moshnikova V, Andreev OA, Reshetnyak YK. Antiproliferative effect of pHLIP-amanitin. Biochemistry. 52: 1171-8. PMID 23360641 DOI: 10.1021/Bi301647Y |
0.457 |
|
| 2013 |
Yao L, Daniels J, Danniels J, Moshnikova A, Kuznetsov S, Ahmed A, Engelman DM, Reshetnyak YK, Andreev OA. pHLIP peptide targets nanogold particles to tumors. Proceedings of the National Academy of Sciences of the United States of America. 110: 465-70. PMID 23267062 DOI: 10.1073/Pnas.1219665110 |
0.433 |
|
| 2013 |
Sosunov EA, Anyukhovsky EP, Sosunov AA, Moshnikova A, Wijesinghe D, Engelman DM, Reshetnyak YK, Andreev OA. pH (low) insertion peptide (pHLIP) targets ischemic myocardium. Proceedings of the National Academy of Sciences of the United States of America. 110: 82-6. PMID 23248283 DOI: 10.1073/Pnas.1220038110 |
0.409 |
|
| 2013 |
Andreev OA, Engelman DM, Reshetnyak YK. Novel Concept of Delivery of Diagnostic and Therapeutic Agents to Cells in Acidic Diseased Tissue using Energy of Membrane-Associated Folding Biophysical Journal. 104: 362a. DOI: 10.1016/J.Bpj.2012.11.2013 |
0.524 |
|
| 2012 |
Reshetnyak YK, Prudence CN, Segala J, Markin VS, Andreev OA. Parking problem and negative cooperativity of binding of myosin subfragment 1 to F-actin. Biochemical and Biophysical Research Communications. 425: 746-9. PMID 22867639 DOI: 10.1016/J.Bbrc.2012.07.146 |
0.674 |
|
| 2012 |
Daumar P, Wanger-Baumann CA, Pillarsetty N, Fabrizio L, Carlin SD, Andreev OA, Reshetnyak YK, Lewis JS. Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation. Bioconjugate Chemistry. 23: 1557-66. PMID 22784215 DOI: 10.1021/Bc3000222 |
0.442 |
|
| 2012 |
Karabadzhak AG, Weerakkody D, Wijesinghe D, Thakur MS, Engelman DM, Andreev OA, Markin VS, Reshetnyak YK. Modulation of the pHLIP transmembrane helix insertion pathway. Biophysical Journal. 102: 1846-55. PMID 22768940 DOI: 10.1016/J.Bpj.2012.03.021 |
0.437 |
|
| 2012 |
Macholl S, Morrison MS, Iveson P, Arbo BE, Andreev OA, Reshetnyak YK, Engelman DM, Johannesen E. In vivo pH imaging with (99m)Tc-pHLIP. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 14: 725-34. PMID 22371188 DOI: 10.1007/S11307-012-0549-Z |
0.423 |
|
| 2011 |
Wijesinghe D, Engelman DM, Andreev OA, Reshetnyak YK. Tuning a polar molecule for selective cytoplasmic delivery by a pH (Low) insertion peptide. Biochemistry. 50: 10215-22. PMID 22029270 DOI: 10.1021/Bi2009773 |
0.449 |
|
| 2011 |
Barrera FN, Weerakkody D, Anderson M, Andreev OA, Reshetnyak YK, Engelman DM. Roles of carboxyl groups in the transmembrane insertion of peptides. Journal of Molecular Biology. 413: 359-71. PMID 21888917 DOI: 10.1016/J.Jmb.2011.08.010 |
0.476 |
|
| 2011 |
Reshetnyak YK, Yao L, Zheng S, Kuznetsov S, Engelman DM, Andreev OA. Measuring tumor aggressiveness and targeting metastatic lesions with fluorescent pHLIP. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 13: 1146-56. PMID 21181501 DOI: 10.1007/S11307-010-0457-Z |
0.484 |
|
| 2011 |
Barrera FN, An M, Wijesinghe DD, Weerakkody DA, Anderson M, Andreev OA, Reshetnyak YK, Engelman DM. Abstract C2: Aspartic acid residues drive the membrane translocation of pHLIP, a therapeutic and imaging agent for solid tumors Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-C2 |
0.539 |
|
| 2011 |
Weerakkody DA, Karabadzhak AG, Thakur MS, Rossi B, Engelman DM, Andreev OA, Reshetnyak YK. Correlation between Properties of pHLIP Peptide-Lipid Interaction and Tumor Targeting In Vivo Biophysical Journal. 100: 498a. DOI: 10.1016/J.Bpj.2010.12.2918 |
0.513 |
|
| 2011 |
Karabadzhak AG, Weerakkody D, Thakur MS, Anderson MD, Engelman DM, Andreev OA, Markin VS, Reshetnyak YK. First Step in Folding of Nonconstitutive Membrane Proteins: Spontaneous Insertion of a Polypeptide into a Lipid Bilayer and Formation of Helical Structure Biophysical Journal. 100: 346a. DOI: 10.1016/J.Bpj.2010.12.2088 |
0.428 |
|
| 2010 |
An M, Wijesinghe D, Andreev OA, Reshetnyak YK, Engelman DM. pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation. Proceedings of the National Academy of Sciences of the United States of America. 107: 20246-50. PMID 21048084 DOI: 10.1073/Pnas.1014403107 |
0.5 |
|
| 2010 |
Andreev OA, Engelman DM, Reshetnyak YK. pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents. Molecular Membrane Biology. 27: 341-52. PMID 20939768 DOI: 10.3109/09687688.2010.509285 |
0.472 |
|
| 2010 |
Andreev OA, Karabadzhak AG, Weerakkody D, Andreev GO, Engelman DM, Reshetnyak YK. pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path. Proceedings of the National Academy of Sciences of the United States of America. 107: 4081-6. PMID 20160113 DOI: 10.1073/Pnas.0914330107 |
0.47 |
|
| 2010 |
Musial-Siwek M, Karabadzhak A, Andreev OA, Reshetnyak YK, Engelman DM. Tuning the insertion properties of pHLIP. Biochimica Et Biophysica Acta. 1798: 1041-6. PMID 19766589 DOI: 10.1016/J.Bbamem.2009.08.023 |
0.498 |
|
| 2010 |
Karabadzhak AG, Weerakkody D, Thakur MS, Andreev GO, Engelman DM, Andreev OA, Reshetnyak YK. Membrane-Associated Folding and Unfolding Biophysical Journal. 98: 88a. DOI: 10.1016/J.Bpj.2009.12.499 |
0.46 |
|
| 2010 |
Barrera FN, Musial-Siwek M, Andreev OA, Reshetnyak YK, Engelman DM. Energy Barriers and Helix Plasticity in the Membrane Insertion of pHLIP Biophysical Journal. 98: 82a. DOI: 10.1016/J.Bpj.2009.12.466 |
0.436 |
|
| 2010 |
An M, Wijesinghe D, Andreev OA, Reshetnyak YK, Engelman DM. Cancer Cell Proliferation is Inhibited by Phlip Mediated Delivery of Membrane Impermeable Toxin Phalloidin Biophysical Journal. 98: 277a-278a. DOI: 10.1016/J.Bpj.2009.12.1516 |
0.386 |
|
| 2009 |
Segala J, Engelman DM, Reshetnyak YK, Andreev OA. Accurate analysis of tumor margins using a fluorescent pH Low Insertion Peptide (pHLIP). International Journal of Molecular Sciences. 10: 3478-87. PMID 20111691 DOI: 10.3390/Ijms10083478 |
0.713 |
|
| 2009 |
Andreev OA, Engelman DM, Reshetnyak YK. Targeting acidic diseased tissue: New technology based on use of the pH (Low) Insertion Peptide (pHLIP). Chimica Oggi. 27: 34-37. PMID 20037661 |
0.403 |
|
| 2009 |
V?vere AL, Biddlecombe GB, Spees WM, Garbow JR, Wijesinghe D, Andreev OA, Engelman DM, Reshetnyak YK, Lewis JS. A novel technology for the imaging of acidic prostate tumors by positron emission tomography. Cancer Research. 69: 4510-6. PMID 19417132 DOI: 10.1158/0008-5472.Can-08-3781 |
0.477 |
|
| 2009 |
Prudence CN, Segala J, Markin V, Reshetnyak Y, Andreev O. Actin - Myosin Interaction Biophysical Journal. 96: 123a. DOI: 10.1016/J.Bpj.2008.12.548 |
0.33 |
|
| 2009 |
Yao L, Zheng S, Engelman DM, Reshetnyak YK, Andreev OA. pHLIP-bionanosyringe for Targeting Acidic Solid Tumors and Selective Delivery of Nanomaterials Biophysical Journal. 96: 632a. DOI: 10.1016/J.Bpj.2008.12.3344 |
0.505 |
|
| 2009 |
Karabadzhak A, Weerakkody D, Engelman DM, Andreev OA, Reshetnyak YK. Kinetics Of Peptide (pHLIP) Insertion And Folding In A Lipid Bilayer Membrane Biophysical Journal. 96: 453a. DOI: 10.1016/J.Bpj.2008.12.2327 |
0.426 |
|
| 2008 |
Reshetnyak YK, Andreev OA, Segala M, Markin VS, Engelman DM. Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane. Proceedings of the National Academy of Sciences of the United States of America. 105: 15340-5. PMID 18829441 DOI: 10.1016/J.Bpj.2008.12.1836 |
0.437 |
|
| 2007 |
Reshetnyak YK, Segala M, Andreev OA, Engelman DM. A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers. Biophysical Journal. 93: 2363-72. PMID 17557792 DOI: 10.1529/Biophysj.107.109967 |
0.488 |
|
| 2007 |
Andreev OA, Dupuy AD, Segala M, Sandugu S, Serra DA, Chichester CO, Engelman DM, Reshetnyak YK. Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo. Proceedings of the National Academy of Sciences of the United States of America. 104: 7893-8. PMID 17483464 DOI: 10.1073/Pnas.0702439104 |
0.532 |
|
| 2007 |
Andreev OA, Reshetnyak YK. Mechanism of formation of actomyosin interface. Journal of Molecular Biology. 365: 551-4. PMID 17081565 DOI: 10.1016/J.Jmb.2006.10.014 |
0.321 |
|
| 2006 |
Reshetnyak YK, Andreev OA, Lehnert U, Engelman DM. Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix. Proceedings of the National Academy of Sciences of the United States of America. 103: 6460-5. PMID 16608910 DOI: 10.1073/Pnas.0601463103 |
0.5 |
|
| 1996 |
Xiao M, Tartakowski A, Andreev OA, Borejdo J. Binding of S1(A1) and S1(A2) to F-actin Biochemistry. 35: 523-530. PMID 8555223 DOI: 10.1021/Bi9511696 |
0.317 |
|
| 1995 |
Andreev OA, Borejdo J. Binding of heavy-chain and essential light-chain 1 of S1 to actin depends on the degree of saturation of F-actin filaments with S1 Biochemistry. 34: 14829-14833. PMID 7578092 DOI: 10.1021/Bi00045A025 |
0.316 |
|
| 1993 |
Andreev OA, Andreeva AL, Borejdo J. Polarization of fluorescently labeled myosin subfragment-1 fully or partially decorating muscle fibers and myofibrils Biophysical Journal. 65: 1027-1038. PMID 8241383 DOI: 10.1016/S0006-3495(93)81161-5 |
0.324 |
|
| 1992 |
Andreev O, Borejdo J. Binding of myosin subfragment-1 to F-actin Biochemical and Biophysical Research Communications. 188: 94-101. PMID 1417872 DOI: 10.1016/0006-291X(92)92354-Z |
0.308 |
|
| 1991 |
Andreev OA, Borejdo J. The myosin head can bind two actin monomers Biochemical and Biophysical Research Communications. 177: 350-356. PMID 2043120 DOI: 10.1016/0006-291X(91)91990-T |
0.304 |
|
| Show low-probability matches. |